<< Back
Aerojet Awarded Missile Defense Contracts

SACRAMENTO, Calif., May 27, 2011 /PRNewswire via COMTEX/ -- Aerojet, a GenCorp (NYSE: GY) company, has been awarded two contracts for the maturation of advanced technologies for Upper Stage and Divert and Attitude Control System propulsion elements of the Standard Missile Blk IIB Interceptor, as part of an Early Intercept Defense Phase of the European Phased Adaptive Approach for the U.S. Missile Defense Agency (MDA).

The Aerojet technologies are intended to provide high-performance, lightweight technology propulsion components that would be used in the upper stage propulsion and for the Kill Vehicle Divert and Attitude Controls. Under these contracts, Aerojet will identify key propulsion technologies, define and conceptualize propulsion components, and conduct limited testing to provide characterization data.

"Aerojet is excited to develop these technologies and provide affordable, high-performance propulsion to the Missile Defense Agency," said Aerojet's Executive Director, Business Development, Peter Massey.

Aerojet is a world-recognized aerospace and defense leader principally serving the missile and space propulsion, defense and armaments markets. GenCorp is a leading technology-based manufacturer of aerospace and defense products and systems with a real estate segment that includes activities related to the entitlement, sale, and leasing of the company's excess real estate assets. Additional information about Aerojet and GenCorp can be obtained by visiting the companies' websites at http://www.aerojet.com/ and http://www.gencorp.com/.

SOURCE Aerojet

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Aerojet Rocketdyne Holdings's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report or Form 10-K for the most recently ended fiscal year.